Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Sees Large Increase in Short Interest

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 15,423,100 shares, a growth of 190.5% from the March 31st total of 5,308,700 shares. Based on an average trading volume of 800 shares, the short-interest ratio is currently 19,278.9 days.

Sino Biopharmaceutical Price Performance

Shares of OTCMKTS SBMFF opened at $0.31 on Friday. The firm’s 50-day moving average price is $0.36 and its two-hundred day moving average price is $0.39. Sino Biopharmaceutical has a 52-week low of $0.32 and a 52-week high of $0.54.

Sino Biopharmaceutical Company Profile

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection.